查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1726345

血液过滤和净化市场规模、份额、趋势分析报告：按产品、应用、最终用途、地区和细分市场预测，2025 年至 2030 年

Blood Filtration And Purification Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10个工作天内

价格

血液滤过和净化市场的成长和趋势

根据Grand View Research, Inc.的最新报告，全球血液过滤和净化市场规模预计到2030年将达到56.3亿美元，2025年至2030年期间的复合年增长率为7.34%。

血源性疾病盛行率的上升、老年人口的增长以及对血液净化疗法的认识的提高等关键驱动因素正在推动市场成长。

由于严重患者迫切需要有效的治疗方案，临床诊断血液过滤和净化产业在新冠疫情期间经历了大幅成长。在此期间，最重要的工具是先进的血液净化套件，它在控制严重的发炎反应、器官衰竭和与病毒相关的併发症发挥了关键作用。

处于这一创新前沿的是OXIRIS，这是一种多功能血液净化过滤器组，也是美国唯一能够从血液中去除细胞激素和发炎介质，同时也能提供持续肾臟替代疗法（CRRT）的产品。在疫情期间，OXIRIS已成为治疗患有细胞激素风暴、败血症和急性肾损伤的严重COVID-19患者的关键治疗方案。透过有效去除发炎物质，该套件有助于稳定患者病情、减轻加护治疗负担并改善生存结果。

Thermo Scientific 的 GeneJET 全血基因组 DNA 纯化迷你试剂套件因其快速、基于旋转管柱的硅胶膜技术而脱颖而出。该套件简化了从全血中提取 DNA 的过程，无需进行危险的苯酚-氯仿提取和耗时的酒精沉淀。标准方案需要不到 20 分钟的裂解后时间，并产生高分子量 DNA（>30 kb），适用于 PCR、Southern 印迹和酶促测定等下游应用。该套件的简单性和可靠性使其成为寻求快速安全地扩大基因组诊断规模的实验室的理想选择。

SpiNXT 血液 DNA 萃取试剂盒是另一种创新解决方案，专为全血、血浆、血清、淋巴细胞和白血球层使用而设计。二氧化硅结合化学和微型旋转管柱形式的结合可以从多种血液样本类型中分离出高产量、高纯度的 DNA。 SpiNXT套件无需有机溶剂或复杂仪器，可快速处理并相容于多种临床基因检测。

另一方面，sbeadex 血液 DNA 纯化试剂盒专注于以微珠为基础的技术。该试剂套件专为高达 200 μL 的样品量而设计，支援高性能自动化工作流程，并与 Thermo Fisher 的 KingFisher™ 系统等流行平台完全相容。水性清洗缓衝液可消除有机溶剂和 PCR 抑制剂的残留，确保洁净的 DNA 适用于 qPCR、NGS、桑格定序和遗传疾病筛检等敏感应用。

此次疫情凸显了血液净化套件在管理高风险患者中的重要角色。随着医疗保健系统适应 COVID-19 的挑战，这些套件不仅已成为辅助诊断而且也用于治疗性介入的重要工具。其影响超越了疫情本身，并继续用于治疗败血症、肾臟损伤和其他发炎引起的疾病。

COVID-19 危机加速了血液过滤和净化套件（例如 OXIRIS、CytoSorb、AMBER 和 Hemoclear）的采用，为综合临床诊断和重症加护树立了新的标准。这些创新仍然是现代 ICU 实践的核心，确保大流行期间获得的经验教训转化为未来更强大、应对力的医疗保健系统。

血液滤过和净化市场报告重点

  • 2024 年，过滤套件和试剂部分将占据市场主导地位，收入份额最大，为 35.97%。该领域在确保输血、医疗和医学研究的安全性和有效性方面发挥着至关重要的作用，预计将迅速扩张。关键驱动因素是过滤材料技术的进步和全球对高品质血液製品的需求不断增长，进一步增强了过滤套件和试剂市场的主导地位。
  • 根据应用，感染疾病诊断领域在 2024 年占据了最大的市场收益占有率。这是由于全球感染疾病疫情日益严重，以及对准确、快速诊断的迫切需求。由于对精准和个人化医疗保健解决方案的需求不断增长，预计预测期内基因/分子诊断领域将以最快的复合年增长率增长。
  • 根据最终用途，临床诊断实验室部门在 2024 年占据了最大的市场收益占有率。这是因为它在疾病检测和监测中发挥着至关重要的作用。这些实验室依靠先进的过滤技术来获取高品质、无污染的血液样本，以进行准确的检测，特别是在感染疾病诊断、基因检测和肿瘤学方面。随着个人化医疗和疾病早期检测的兴起，临床诊断实验室正在采用尖端过滤技术，推动这一细分市场的规模和成长。

目录

第一章调查方法与范围

第二章执行摘要

第三章血液过滤和净化市场变​​数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 血液过滤和净化市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析

第四章血液过滤和净化市场：按产品分類的估计和趋势分析

  • 血液滤过和净化市场：产品仪表板
  • 全球血液滤过和净化市场的产品趋势分析
  • 全球血液滤过与净化市场：产品展望
  • 过滤试剂套件和试剂
  • 薄膜、过滤器和耗材
  • 样品製备系统
  • 专用分析试剂与管柱

第五章血液过滤和净化市场：按应用进行的估计和趋势分析

  • 血液滤过和净化市场：应用仪表板
  • 全球血液过滤与净化市场应用变化分析
  • 全球血液滤过与净化市场：应用展望
  • 感染疾病诊断
  • 毒理学和免疫诊断学
  • 癌症诊断
  • 基因/分子诊断
  • 其他（代谢、罕见疾病小组）

第六章。血液过滤和净化市场：按最终用途的估计和趋势分析

  • 血液滤过和净化市场：最终用途仪表板
  • 全球血液滤过和净化市场最终用途趋势分析
  • 全球血液滤过和净化市场：依最终用途分類的展望
  • 临床诊断
  • 医院
  • 研究和学术机构
  • 其他的

第七章。血液过滤和净化市场：按产品、应用、最终用途和地区进行的估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • 2024年主要企业市场占有率分析
    • Thermo Fischer Scientific
    • MilliporeSigma
    • Roche Lifescience
    • Sigma Aldrich
    • Avantor.
    • Takara Bio
    • MP Biomedicals
    • QIAGEN NV
    • HiMedia
    • BIoTage
Product Code: GVR-4-68040-560-0

Blood Filtration And Purification Market Growth & Trends:

The global blood filtration and purification market size is anticipated to reach USD 5.63 billion by 2030 and is projected to grow at a CAGR of 7.34% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key driving factors such as increasing prevalence of blood-borne diseases, growing geriatric population, rising awareness of blood purification therapies have fueled the market growth.

The blood filtration & purification industry in clinical diagnostics experienced a major surge during the COVID-19 pandemic, driven by the urgent need for effective treatment solutions for critically ill patients. Among the most vital tools during this period were advanced blood purification kits, which played a critical role in managing severe inflammatory responses, organ failure, and complications associated with the virus.

At the forefront of this innovation was OXIRIS, a multifunctional blood purification filter set-the only one available in the U.S. capable of performing Continuous Renal Replacement Therapy (CRRT) while simultaneously removing cytokines and inflammatory mediators from the blood. During the height of the pandemic, OXIRIS became a key therapeutic solution for managing critically ill COVID-19 patients who were experiencing cytokine storms, sepsis, and acute kidney injury. By efficiently removing inflammatory substances, the kit helped stabilize patients, reduce intensive care burden, and improve survival outcomes.

Thermo Scientific's GeneJET Whole Blood Genomic DNA Purification Mini Kit stands out for its rapid, spin-column-based silica membrane technology. This kit streamlines DNA extraction from whole blood, eliminating the need for hazardous phenol-chloroform extraction or time-consuming alcohol precipitation. With a standard protocol that takes under 20 minutes post-lysis, it delivers high molecular weight DNA (>30 kb), ready for downstream applications like PCR, Southern blotting, and enzymatic assays. The kit's simplicity and reliability make it a preferred choice for laboratories looking to scale genomic diagnostics with speed and safety.

SpiNXT Blood DNA Extraction Kit is another innovative solution, designed for use with whole blood, plasma, serum, lymphocytes, and buffy coat. Combining silica-binding chemistry with a mini spin-column format, it ensures high-yield, high-purity DNA isolations across a range of blood-derived sample types. With no need for organic solvents or complicated equipment, the SpiNXT kit enables fast processing and compatibility with a wide array of clinical genetic assays.

Meanwhile, the sbeadex Blood DNA Purification Kit brings magnetic bead-based technology into focus. Designed for sample volumes up to 200 µL, the kit supports high-throughput automation workflows and is fully compatible with popular platforms like Thermo Fisher's KingFisher(TM) system. Its water-based wash buffers help eliminate carryover of organic solvents and PCR inhibitors, ensuring clean DNA suitable for sensitive applications such as qPCR, NGS, Sanger sequencing, and genetic disorder screening.

The pandemic highlighted the critical role of blood purification kits in managing high-risk patients. As healthcare systems adapted to the challenges of COVID-19, these kits became indispensable tools not only for diagnostic support but also for therapeutic intervention. Their impact has extended beyond the pandemic, with continued use in managing sepsis, kidney injury, and other inflammation-driven conditions.

The COVID-19 crisis accelerated the adoption of blood filtration and purification kits such as OXIRIS, CytoSorb, AMBER, and Hemoclear, setting a new benchmark for integrated clinical diagnostics and critical care. These innovations remain central to modern ICU practice, ensuring that the lessons learned during the pandemic translate into stronger, more responsive healthcare systems going forward.

Blood Filtration And Purification Market Report Highlights:

  • The filtration kits & reagents segment led the market with the largest revenue share of 35.97% in 2024. This segment is expected to see rapid expansion due to its critical role in ensuring the safety and efficacy of blood transfusions, therapeutic treatments, and medical research. A key driving factor is the technological advancements in filtration materials, and a growing global demand for high-quality blood products further contributes to the dominance of filtration kits and reagents in the market.
  • Based on application, the infectious disease diagnostics segment accounted for the largest market revenue share in 2024, due to the growing global prevalence of infectious diseases and the critical need for accurate, rapid diagnostics. The genetic/molecular diagnostics segment is expected to grow at the fastest CAGR over the forecast period, due to the increasing demand for precise, personalized healthcare solutions.
  • Based on end use, the clinical diagnostics laboratories segment accounted for the largest market revenue share in 2024, due to their essential role in disease detection and monitoring. These laboratories rely on advanced filtration technologies to obtain high-quality, contaminant-free blood samples for accurate testing, especially in infectious disease diagnostics, genetic testing, and oncology. With the rise of personalized medicine and early disease detection, clinical diagnostic labs are adopting cutting-edge filtration technologies, driving both the size and growth of this market segment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Blood Filtration & Purification Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD)
      • 3.2.1.2. Increasing prevalence of bloodborne diseases
      • 3.2.1.3. Advancements in hemodialysis and renal care
      • 3.2.1.4. Rising Demand for safe blood transfusions
      • 3.2.1.5. Technological advancements in filtration and purification systems
      • 3.2.1.6. Growing use of liquid biopsy for cancer diagnostics
      • 3.2.1.7. Regulatory push for improved blood safety standards
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High equipment costs
      • 3.2.2.2. Lack of awareness and skilled professionals
  • 3.3. Blood Filtration & Purification Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Blood Filtration & Purification Market: Product Estimates & Trend Analysis

  • 4.1. Blood Filtration & Purification Market: Product Dashboard
  • 4.2. Global Blood Filtration & Purification Market Product Movement Analysis
  • 4.3. Global Blood Filtration & Purification Market by Product Outlook
  • 4.4. Filtration kits and Reagents
    • 4.4.1. Filtration kits and Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Membranes, Filters and Consumables
    • 4.5.1. Membranes, Filters and Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Sample preparation systems
    • 4.6.1. Sample preparation systems market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Specialty assays and columns
    • 4.7.1. Specialty assays and columns market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Blood Filtration & Purification Market: Application Estimates & Trend Analysis

  • 5.1. Blood Filtration & Purification Market: Application Dashboard
  • 5.2. Global Blood Filtration & Purification Market Application Movement Analysis
  • 5.3. Global Blood Filtration & Purification Market by Application Outlook
  • 5.4. Infectious Disease Diagnostics
    • 5.4.1. Infectious Disease Diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Toxicology and Immunodiagnostics
    • 5.5.1. Toxicology and Immunodiagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Cancer Diagnostics
    • 5.6.1. Cancer Diagnostics market estimates and forecasts, 2018 to 2030, (USD Million)
  • 5.7. Genetic/Molecular Diagnostics
    • 5.7.1. Genetic/Molecular Diagnostics market estimates and forecasts, 2018 to 2030, (USD Million)
  • 5.8. Others (Metabolic, Rare Disease Panels
    • 5.8.1. Genetic/Molecular Diagnostics market estimates and forecasts, 2018 to 2030, (USD Million)

Chapter 6. Blood Filtration & Purification Market: End-use Estimates & Trend Analysis

  • 6.1. Blood Filtration & Purification Market: End-use Dashboard
  • 6.2. Global Blood Filtration & Purification Market End-use Movement Analysis
  • 6.3. Global Blood Filtration & Purification Market by End-use Outlook
  • 6.4. Clinical Diagnostics
    • 6.4.1. Clinical Diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Research and Academic Institutes
    • 6.6.1. Research and Academic Institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Blood Filtration & Purification Market: Regional Estimates & Trend Analysis by Product, Application and End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Thermo Fischer Scientific
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. MilliporeSigma
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Roche Lifescience
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Sigma Aldrich
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Avantor.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Takara Bio
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. MP Biomedicals
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. QIAGEN N.V
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. HiMedia
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Biotage
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table. 1. List of abbreviation
  • Table. 2. North America blood filtration & purification market, by region, 2018 - 2030 (USD Million)
  • Table. 3. North America blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 4. North America blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 5. North America blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 6. U.S. blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 7. U.S. blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 8. U.S. blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 9. Canada blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 10. Canada blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 11. Canada blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 12. Mexico blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 13. Mexico blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 14. Mexico blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 15. Europe blood filtration & purification market, by region, 2018 - 2030 (USD Million)
  • Table. 16. Europe blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 17. Europe blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 18. Europe blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 19. Germany blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 20. Germany blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 21. Germany blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 22. UK blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 23. UK blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 24. UK blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 25. France blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 26. France blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 27. France blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 28. Italy blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 29. Italy blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 30. Italy blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 31. Spain blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 32. Spain blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 33. Spain blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 34. Denmark blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 35. Denmark blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 36. Denmark blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 37. Sweden blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 38. Sweden blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 39. Sweden blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 40. Norway blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 41. Norway blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 42. Norway blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 43. Asia Pacific blood filtration & purification market, by region, 2018 - 2030 (USD Million)
  • Table. 44. Asia Pacific blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 45. Asia Pacific blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 46. Asia Pacific blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 47. China blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 48. China blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 49. China blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 50. Japan blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 51. Japan blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 52. Japan blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 53. India blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 54. India blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 55. India blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 56. South Korea blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 57. South Korea blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 58. South Korea blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 59. Australia blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 60. Australia blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 61. Australia blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 62. Thailand blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 63. Thailand blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 64. Thailand blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 65. Latin America blood filtration & purification market, by region, 2018 - 2030 (USD Million)
  • Table. 66. Latin America blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 67. Latin America blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 68. Latin America blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 69. Brazil blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 70. Brazil blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 71. Brazil blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 72. Mexico blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 73. Argentina blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 74. Argentina blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 75. Argentina blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 76. MEA blood filtration & purification market, by region, 2018 - 2030 (USD Million)
  • Table. 77. MEA blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 78. MEA blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 79. MEA blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 80. South Africa blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 81. South Africa blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 82. South Africa blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 83. Saudi Arabia blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 84. Saudi Arabia blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 85. Saudi Arabia blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 86. UAE blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 87. UAE blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 88. UAE blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 89. Kuwait blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 90. Kuwait blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 91. Kuwait blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Blood filtration & purification market: market outlook
  • Fig. 14 Blood filtration & purification competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Blood filtration & purification market driver impact
  • Fig. 18 Blood filtration & purification market restraint impact
  • Fig. 19 Blood filtration & purification market: Product movement analysis
  • Fig. 20 Blood filtration & purification market: Product outlook and key takeaways
  • Fig. 21 Filtration kits and reagents estimates and forecast, 2018 - 2030
  • Fig. 22 Membrane, filters and consumables estimates and forecast, 2018 - 2030
  • Fig. 23 Sample Preparation Systems estimates and forecast, 2018 - 2030
  • Fig. 24 Specialty Assays/Columns estimates and forecast, 2018 - 2030
  • Fig. 25 Blood filtration & purification market: Application movement analysis
  • Fig. 26 Blood filtration & purification market: Application outlook and key takeaways
  • Fig. 27 Infectious Disease Diagnostics market estimates and forecast, 2018 - 2030
  • Fig. 28 Toxicology and Immunodiagnostics estimates and forecast, 2018 - 2030
  • Fig. 29 Cancer Diagnostics market estimates and forecast, 2018 - 2030
  • Fig. 30 Genetic/Molecular Diagnostics market estimates and forecast, 2018 - 2030
  • Fig. 31 Others estimates and forecast, 2018 - 2030
  • Fig. 32 Blood filtration & purification market: End-use movement analysis
  • Fig. 33 Blood filtration & purification market: End-use outlook and key takeaways
  • Fig. 34 Clinical Diagnostics market estimates and forecast, 2018 - 2030
  • Fig. 35 Hospitals estimates and forecast, 2018 - 2030
  • Fig. 36 Research and Academic Institutes estimates and forecast, 2018 - 2030
  • Fig. 37 Others market estimates and forecast, 2018 - 2030
  • Fig. 38 Global blood filtration & purification market: Regional movement analysis
  • Fig. 39 Global blood filtration & purification market: Regional outlook and key takeaways
  • Fig. 40 Global blood filtration & purification market share and leading players
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030
  • Fig. 42 US key country dynamics
  • Fig. 43 US market estimates and forecasts, 2018 - 2030
  • Fig. 44 Canada key country dynamics
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 46 Mexico key country dynamics, 2018 - 2030
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 48 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 49 UK key country dynamics
  • Fig. 50 UK market estimates and forecasts, 2018 - 2030
  • Fig. 51 Germany key country dynamics
  • Fig. 52 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 53 France key country dynamics
  • Fig. 54 France market estimates and forecasts, 2018 - 2030
  • Fig. 55 Italy key country dynamics
  • Fig. 56 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 57 Spain key country dynamics
  • Fig. 58 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 59 Denmark key country dynamics
  • Fig. 60 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 61 Sweden key country dynamics
  • Fig. 62 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 63 Norway key country dynamics
  • Fig. 64 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 66 China key country dynamics
  • Fig. 67 China market estimates and forecasts, 2018 - 2030
  • Fig. 68 Japan key country dynamics
  • Fig. 69 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 70 India key country dynamics
  • Fig. 71 India market estimates and forecasts, 2018 - 2030
  • Fig. 72 Thailand key country dynamics
  • Fig. 73 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 74 South Korea key country dynamics
  • Fig. 75 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 76 Australia key country dynamics
  • Fig. 77 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 78 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 79 Brazil key country dynamics
  • Fig. 80 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 81 Argentina key country dynamics
  • Fig. 82 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 83 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 84 South Africa key country dynamics
  • Fig. 85 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 86 Saudi Arabia key country dynamics
  • Fig. 87 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 88 UAE key country dynamics
  • Fig. 89 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 90 Kuwait key country dynamics
  • Fig. 91 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 92 Market share of key market players - Blood filtration & purification market